Brian M. Silver T Scan Therapeutics, Inc. (TCRX) insider trading activity

TCRX Quotes by TradingView

Brian M. Silver is Chief Financial Officer of TScan Therapeutics, Inc.. Currently has a direct ownership of 32,885 shares of TCRX, which is worth approximately $187,773. The most recent transaction as insider was on Dec 28, 2022, when has been sold 3,158 shares (Voting Common Stock) at a price of $1.56 per share, resulting in proceeds of $4,926. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.9K
0% 3M change
0% 12M change
Total Value Held $187,773

Brian M. Silver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2022
BUY
Open market or private purchase
$4,926 $1.56 p/Share
3,158 Added 8.76%
32,885 Voting Common Stock
Dec 27 2022
BUY
Open market or private purchase
$4,263 $1.5 p/Share
2,842 Added 8.73%
29,727 Voting Common Stock
Mar 24 2022
BUY
Open market or private purchase
$51,000 $3.4 p/Share
15,000 Added 35.81%
26,885 Voting Common Stock
Sep 21 2021
BUY
Open market or private purchase
$31,600 $6.32 p/Share
5,000 Added 29.61%
11,885 Voting Common Stock
Sep 09 2021
BUY
Open market or private purchase
$49,905 $8.48 p/Share
5,885 Added 46.08%
6,885 Voting Common Stock
Jul 20 2021
BUY
Open market or private purchase
$15,000 $15.0 p/Share
1,000 Added 50.0%
1,000 Voting Common Stock
Brian M. Silver

Brian M. Silver

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on TCRX

Follow TScan Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRX shares.

Notify only if

Insider Trading

Get notified when an T Scan Therapeutics, Inc. insider buys or sells TCRX shares.

Notify only if

News

Receive news related to TScan Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRX